Tuberculosis

Pai, Madhukar, Behr, Marcel A., Dowdy, David, Dheda, Keertan, Divangahi, Maziar, Boehme, Catharina C., Ginsberg, Ann, Swaminathan, Soumya +4 more·2016·Nature Reviews Disease Primers

Cited by (1,000)

Items 201–300 of 1,000

  1. STAT1 and CXCL10 involve in M1 macrophage polarization that may affect osteolysis and bone remodeling in extrapulmonary tuberculosis
    Tuo Liang, Jiarui Chen, Guoyong Xu, Zide Zhang, Jiang Xue, Haopeng Zeng, Jie Jiang, Tianyou Chen, Zhaojie Qin, Hao Li et al. · 2021 · Gene
  2. A structural overview of mycobacterial adhesins: Key biomarkers for diagnostics and therapeutics
    Flavia Squeglia, Alessia Ruggiero, Alfonso De Simone, Rita Berisio · 2017 · Protein Science
  3. Tuberkulose im Erwachsenenalter
    Tom Schaberg, Folke Brinkmann, Cornelia Feiterna‐Sperling, Hilte Friederike Geerdes-Fenge, Pia Hartmann, Brit Häcker, Barbara Hauer, Walter Haas, Jan Heyckendorf, Christoph G. Lange et al. · 2022 · Pneumologie
  4. BTS clinical statement for the diagnosis and management of ocular tuberculosis
    Onn Min Kon, Nicholas A. V. Beare, David W. Connell, Erika Marie Damato, Thomas Gorsuch, Guy Hagan, Felicity Perrin, Harry Petrushkin, Jessica Potter, Charanjit S. Sethi et al. · 2022 · BMJ Open Respiratory Research
  5. CD4 T cell dysfunction is associated with bacterial recrudescence during chronic tuberculosis
    Evelyn Chang, Kelly Cavallo, Samuel M. Behar · 2025 · Nature Communications
  6. Dynamical Organization of Compositionally Distinct Inner and Outer Membrane Lipids of Mycobacteria
    Pranav Adhyapak, Aswin T. Srivatsav, Manjari Mishra, Abhishek Singh, Rishikesh Narayan, Shobhna Kapoor · 2020 · Biophysical Journal
  7. Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis
    Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Vijay Viswanathan, Kannan Thiruvengadam, Dina Nair, Vaithilingam V. Banurekha, Shanmugam Sivakumar, Syed S Hissar, Hardy Kornfeld et al. · 2020 · Clinical Infectious Diseases
  8. Diagnosis of opportunistic infections
    Lesley Erica Scott, Pedro F. Silva, Catharina C. Boehme, Wendy Susan Stevens, Christopher M. Gilpin · 2017 · Current Opinion in HIV and AIDS
  9. The quest for vaccine-induced immune correlates of protection against tuberculosis
    Elisa Nemes, Andrew J. Fiore-Gartland, César Boggiano, Margherita Coccia, Patricia D’Souza, Peter B. Gilbert, Ann M. Ginsberg, Ollivier Hyrien, Dominick J. Laddy, Karen W. Makar et al. · 2022 · Vaccine Insights
  10. Target Identification in Anti-Tuberculosis Drug Discovery
    Rita Capela, Rita Félix, Marta Clariano, Diogo Nunes, Maria de Jesus Perry, Francisca Lopes · 2023 · International Journal of Molecular Sciences
  11. PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection
    Anneliese S. Ashhurst, Thaigarajan Parumasivam, John Gar Yan Chan, Leon C. W. Lin, Manuela Flórido, Nicholas P. West, Hak‐Kim Chan, Warwick J. Britton · 2018 · PLoS ONE
  12. Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi
    Susanne H. Kirsch, F. P. Jake Haeckl, Rolf Müller · 2022 · Natural Product Reports
  13. Human genetics of mycobacterial disease
    Monica Dallmann-Sauer, Wilian Correa-Macedo, Erwin Schurr · 2018 · Mammalian Genome
  14. Modulating Iron for Metabolic Support of TB Host Defense
    James Joseph Phelan, Sharee A. Basdeo, Simone C. Tazoll, Sadhbh McGivern, Judit Rial Saborido, Joseph Keane · 2018 · Frontiers in Immunology
  15. Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities
    Alba Llibre, Martin J Dedicoat, Julie G. Burel, Caroline Demangel, Matthew K. O’Shea, Claudio Mauro · 2021 · Frontiers in Immunology
  16. Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis
    Ahmad Z. Bahlool, Sarinj Fattah, Andrew O’Sullivan, Brenton Cavanagh, Ronan J. MacLoughlin, Joseph Keane, Mary P. O’Sullivan, Sally‐Ann Cryan · 2022 · Pharmaceutics
  17. Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes
    Ardiyah Nurul Fitri Marzaman, Tri Puspita Roska, Sartini Sartini, Rifka Nurul Utami, Sulistiawati Sulistiawati, Cindy Kristina Enggi, Marianti A. Manggau, Latifah Rahman, Venkatram Prasad Shastri, Andi Dian Permana · 2023 · Antibiotics
  18. Role of B Cells in Mycobacterium Tuberculosis Infection
    Paul Stewart, Shivani Patel, Andrew Comer, Shafi Muneer, Uzma Nawaz, Violet Quann, Mira Bansal, Vishwanath Venketaraman · 2023 · Vaccines
  19. NIR-II aggregation-induced emission nanoparticles camouflaged with preactivated macrophage membranes for phototheranostics of pulmonary tuberculosis
    Dingyuan Yan, Xue Li, Huanhuan Wang, Bin Li, Wei Wang, Yuhui Liao, Ben Zhong Tang, Dong Wang · 2025 · Nature Protocols
  20. Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis
    Javeed Ali Shah, Cecilia S. Lindestam Arlehamn, David J. de L. Horne, Alessandro Sette, Thomas R. Hawn · 2019 · The Journal of Infectious Diseases
  21. Inhaled Antibiotics for Mycobacterial Lung Disease
    Brandon J. H. Banaschewski, Thomas Hofmann · 2019 · Pharmaceutics
  22. Metabolic activity of mature biofilms of Mycobacterium tuberculosis and other non-tuberculous mycobacteria
    Anna Solokhina, David Brückner, Gernot Bonkat, Olivier Braissant · 2017 · Scientific Reports
  23. Photoclick Reaction Constructs Glutathione-Responsive Theranostic System for Anti-Tuberculosis
    Judun Zheng, Xun Long, Hao Chen, Zhisheng Ji, Bowen Shu, Rui Yue, Yechun Liao, Shengchao Ma, Kun Qiao, Ying Liu et al. · 2022 · Frontiers in Molecular Biosciences
  24. Single-cell profiling reveals distinct subsets of CD14+ monocytes drive blood immune signatures of active tuberculosis
    Hannah Hillman, Nabeela A. Khan, Akul Singhania, Paige Dubelko, Ferran Soldevila, Rashmi Tippalagama, Aruna Dharshan De Silva, Bandu Gunasena, Judy Perera, Thomas J. Scriba et al. · 2023 · Frontiers in Immunology
  25. Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy
    Yilin Liu, Jiajun Wang, Jiayi Yang, Jiaojiao Xia, Jiaqi Yu, Dongsheng Chen, Yuhe Huang, Fen Yang, Yongdui Ruan, Jun‐Fa Xu et al. · 2024 · Journal of Nanobiotechnology
  26. Early and opposing neutrophil and CD4 T cell responses shape pulmonary tuberculosis pathology
    Benjamin Henry Gern, Josepha M. Klas, Kimberly A. Foster, Molly E. Kanagy, Sara B. Cohen, Courtney Ray Plumlee, Fergal J. Duffy, Maxwell Lewis Neal, Mehnaz Halima, Andrew T. Gustin et al. · 2025 · The Journal of Experimental Medicine
  27. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis
    Phuong Chi Nguyen, Vincent Delorme, Anaïs Bénarouche, Alexandre Guy, Valérie Landry, Stéphane Audebert, Matthieu Pophillat, Luc Camoin, Céline Crauste, Jean‐Marie Galano et al. · 2018 · Bioorganic Chemistry
  28. Mycobacterium tuberculosis Rv3463 induces mycobactericidal activity in macrophages by enhancing phagolysosomal fusion and exhibits therapeutic potential
    Hye‐Soo Park, Yong Woo Back, Ki‐Won Shin, Hyun Shik Bae, Kang-In Lee, Han‐Gyu Choi, Seunga Choi, Hwang-Ho Lee, Chul Hee Choi, Jeong‐Kyu Park et al. · 2019 · Scientific Reports
  29. First clinical evaluation of the QIAreach TM QuantiFERON-TB for tuberculosis infection and active pulmonary disease
    Kiyoyasu Fukushima, Kazumasa Akagi, A. Kondo, T. Kubo, Noriho Sakamoto, Hiroshi Mukae · 2021 · Pulmonology
  30. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV
    Ruvandhi R. Nathavitharana, Philip A. Lederer, Marty Chaplin, Stephanie Bjerrum, Karen R Steingart, Maunank Shah · 2021 · Cochrane Database of Systematic Reviews
  31. The pathogenesis of post-primary tuberculosis. A game changer for vaccine development
    Robert Lee Hunter, Jeffrey K. Actor · 2019 · Tuberculosis
  32. Latent Tuberculosis and HIV Infection
    Sara Hurtado Bares, Susan Swindells · 2020 · Current Infectious Disease Reports
  33. Host-Pathogen Dialogues in Autophagy, Apoptosis, and Necrosis during Mycobacterial Infection
    Jin Kyung Kim, Prashanta Silwal, Eun‐Kyeong Jo · 2020 · Immune Network
  34. Nuclease activity: an exploitable biomarker in bacterial infections
    Javier García González, Frank J. Hernández · 2022 · Expert Review of Molecular Diagnostics
  35. Antibiotic Resistance to Mycobacterium tuberculosis and Potential Use of Natural and Biological Products as Alternative Anti-Mycobacterial Agents
    Roberto Arrigoni, Andrea Ballini, Skënder Topi, Lucrezia Bottalico, Emilio Jirillo, Luigì Santacroce · 2022 · Antibiotics
  36. Treatment of Latent Tuberculosis Infection
    Connie A. Haley · 2017 · Microbiology Spectrum
  37. Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: A retrospective cohort analysis
    Laila Almeida Viana, Marina Pontello Cristelli, Daniel Wagner de Castro Lima Santos, Melissa G. Tavares, Marcus Taver Costa Dantas, Cláudia Rosso Felipe, Helio Tedesco Silva Junior, Jose Osmar Medina-Pestana · 2018 · American Journal of Transplantation
  38. Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis
    Vadim Makarov, Elena G. Salina, Robert C. Reynolds, Phyo Phyo Kyaw Zin, Sean Ekins · 2020 · Journal of Medicinal Chemistry
  39. Tracking down the White Plague. Chapter two: The role of endocranial abnormal blood vessel impressions and periosteal appositions in the paleopathological diagnosis of tuberculous meningitis
    Olga Spekker, Michael Schultz, László Paja, Orsolya Anna Váradi, Erika Molnár, György Pálfi, David R. Hunt · 2020 · PLoS ONE
  40. Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease
    Lindsey E. Fox, Marissa C. Locke, Deborah J. Lenschow · 2020 · Frontiers in Immunology
  41. Benchmarking Machine Learning Models to Assist in the Prognosis of Tuberculosis
    Maicon Herverton Lino Ferreira da Silva Barros, Geovanne Oliveira Alves, Lubnnia Morais Florêncio Souza, Élisson da Silva Rocha, João Fausto Lorenzato de Oliveira, Theo Lynn, Vanderson de Souza Sampaio, Patrícia Takako Endo · 2021 · Informatics
  42. Stabilization of Hypoxia-Inducible Factor Promotes Antimicrobial Activity of Human Macrophages Against Mycobacterium tuberculosis
    Sebastian F. Zenk, Sebastian Hauck, Daniel Mayer, Mark Grieshober, Steffen Stenger · 2021 · Frontiers in Immunology
  43. Evolution of cytokine production capacity in ancient and modern European populations
    Jorge Domínguez‐Andrés, Yunus Kuijpers, Olivier B. Bakker, Martin Jaeger, Cheng‐Jian Xu, Jos W. M. van der Meer, Mattias Jakobsson, Jaume Bertranpetit, Leo A. B. Joosten, Yang Li et al. · 2021 · eLife
  44. Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis
    Nadège Nziza, Deniz Cizmeci, Leela R. L. Davies, Edward B. Irvine, Wonyeong Jung, Brooke A. Fenderson, Marwou de Kock, Willem Albert Hanekom, Kees L. M. C. Franken, Cheryl L. Day et al. · 2022 · Frontiers in Immunology
  45. Beyond latent and active tuberculosis: a scoping review of conceptual frameworks
    S. M. Zaidi, A. Coussens, J. Seddon, T. Kredo, D. Warner, R. Houben, H. Esmail · 2023 · EClinicalMedicine
  46. Structure of mycobacterial respiratory complex I
    Liang, Yingke, Plourde, Alicia, Bueler, Stephanie A., Liu, Jun, Brzezinski, Peter, Vahidi, Siavash, Rubinstein, John L. · 2023 · Proceedings of the National Academy of Sciences
  47. Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy
    Hsing-Wu Chen, Yao-Wen Kuo, Chung‐Yu Chen, Chin-Hao Chang, Su-Mei Wang, Ying‐Chun Chien, Jo‐Pai Chen, Jo-Pai Chen, Cheng‐Yu Chang, Yu‐Feng Wei et al. · 2024 · The Oncologist
  48. Anti-mycobacterial, -oxidative, -proliferative and -inflammatory activities of dichloromethane leaf extracts of Gymnosporia senegalensis (Lam.) Loes
    Marema Ephraim Makgatho, Winston Nxumalo, Lerato A. Raphoko · 2017 · South African Journal of Botany
  49. Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitis
    Charles W. Flexner, David L. Thomas, Susan Swindells · 2018 · Current Opinion in HIV and AIDS
  50. Galleria mellonella: An Infection Model for Screening Compounds Against the Mycobacterium tuberculosis Complex
    Masanori Asai, Yan-Wen Li, Jasmeet Singh Khara, Brian D. Robertson, Paul Richard Langford, Sandra M. Newton · 2019 · Frontiers in Microbiology
  51. An Opportunity to END TB: Using the Sustainable Development Goals for Action on Socio-Economic Determinants of TB in High Burden Countries in WHO South-East Asia and the Western Pacific Regions
    Srinath Satyanarayana, Pruthu Thekkur, Ajay M. V. Kumar, Yan Lin, Riitta A. Dlodlo, Mohammed Ahmed Khogali, Rony Zachariah, Anthony David Harries · 2020 · Tropical Medicine and Infectious Disease
  52. Experimental Pulmonary Tuberculosis in the Absence of Detectable Brain Infection Induces Neuroinflammation and Behavioural Abnormalities in Male BALB/c Mice
    Jacqueline V. Lara-Espinosa, Ricardo A. Santana-Martínez, Perla D. Maldonado, Mario A. Zetter, Enrique Becerril‐Villanueva, Gilberto Pérez‐Sánchez, Lenin Pavón, Dulce Mata‐Espinosa, Jorge Barrios‐Payán, Manuel Othoniel López-Torres et al. · 2020 · International Journal of Molecular Sciences
  53. Global Control of Tuberculosis: Current Status and Future Prospects
    Fei Huang, Yanlin Zhao · 2022 · Zoonoses
  54. Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis
    Arbi Abnousian, Joshua Vasquez, Kayvan Sasaninia, Melissa Kelley, Vishwanath Venketaraman · 2023 · Biomedicines
  55. Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages
    Anirudh Gairola, Aaron B. Benjamin, Joshua D. Weatherston, Jeffrey D. Cirillo, Hung‐Jen Wu · 2022 · Advanced Therapeutics
  56. Mycobacterium Tuberculosis Infection after Kidney Transplantation: A Comprehensive Review
    Bogdan Marian Sorohan, Gener Ismail, Dorina Tacu, Bogdan Obrișcă, Gina Ciolan, Costin Gîngu, Ioanel C. Sinescu, Catalin Baston · 2022 · Pathogens
  57. Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations
    Deivide Oliveira-de-Souza, Caian L. Vinhaes, María B. Arriaga, Nathella Pavan Kumar, Juan Manuel Cubillos-Angulo, Ruiru Shi, Wang Wei, Xing Yuan, Guolong Zhang, Ying Cai et al. · 2019 · Scientific Reports
  58. POTENTIALITIES OF IMMUNOLOGICAL TESTS IN THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION AND TUBERCULOSIS
    L. V. Slogotskaya, Mikhail Valerevich Sinitsyn, Dmitry Anatolievich Kudlay · 2019 · Tuberculosis and lung diseases
  59. Whole blood mRNA expression-based targets to discriminate active tuberculosis from latent infection and other pulmonary diseases
    Jéssica Dias Petrilli, Luana E. Araújo, Luciane Sussuchi da Silva, Ana Carolina Laus, Igor Müller, Rui Manuel Reis, Eduardo Martins Netto, Lee W. Riley, Sérgio Marcos Arruda, Adriano Queiroz · 2020 · Scientific Reports
  60. RNA-Seq Transcriptome Analysis of Peripheral Blood From Cattle Infected With Mycobacterium bovis Across an Experimental Time Course
    Kirsten E. McLoughlin, Carolina N. Correia, John Arthur Browne, David A. Magee, Nicolas Nalpas, Kévin Rue-Albrecht, Adam O. Whelan, Bernardo Villarreal‐Ramos, Hans Martin Vordermeier, Eamonn P. Gormley et al. · 2021 · Frontiers in Veterinary Science
  61. Fluorogenic RNA aptamer output sensors via transcription activated by recombinase polymerase amplification for nucleic acid testing
    Jiajie Liang, Xin Liu, Wei Xiao, Peijun Teng, Ping Guan, Wanli Liang, Liangshan Hu, Guanbo He, Haorong He, Gan Li et al. · 2024 · Chemical Engineering Journal
  62. Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)
    Eman F. Khaleel, Ahmed Sabt, Małgorzata Korycka‐Machała, Rehab Mustafa Badi, Ninh The Son, Nguyen Xuan Ha, Mohamed Farouk Hamissa, Ahmed E. Elsawi, Eslam B. Elkaeed, Bozena R. Dziadek et al. · 2024 · Bioorganic Chemistry
  63. Incomplete transcripts dominate the Mycobacterium tuberculosis transcriptome
    Xiangwu Ju, Shuqi Li, Ruby Froom, Ling Wang, Mirjana Lilić, Madeleine Delbeau, Elizabeth A. Campbell, Jeremy M. Rock, Shixin Liu · 2024 · Nature
  64. Surgical treatment of spinal tuberculosis: an updated review
    Jinjing Gan, Chuanzhi Zhang, Dagang Tang, Xing Du · 2024 · European journal of medical research
  65. Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review
    Violet N Chihota, Makaita Gombe, Amita Gupta, Nicole Salazar‐Austin, Theresa S. Ryckman, Christopher J. Hoffmann, Sylvia M. LaCourse, Jyoti S. Mathad, Vidya Mave, Kelly E. Dooley et al. · 2024 · Drugs
  66. HIV and the tuberculosis “set point”: how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease
    Sara C. Auld, Bashar S. Staitieh · 2020 · Retrovirology
  67. Diagnostic accuracy of TB-LAMP assay in patients with pulmonary tuberculosis–a case-control study in northern India
    R. Yadav, Priya Daroch, Parakriti Gupta, Priyanka Agarwal, A.N. Aggarwal, Sunil Kumar Sethi · 2020 · Pulmonology
  68. Visualizing the dynamics of tuberculosis pathology using molecular imaging
    Alvaro A. Ordoñez, Elizabeth W. Tucker, Carolyn J. Anderson, Claire L. Carter, Shashank Ganatra, Deepak Kaushal, Igor Kramnik, Philana Ling Lin, Cressida A. Madigan, Susana Mendez et al. · 2021 · Journal of Clinical Investigation
  69. Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward
    Mainak Bardhan, Mohammad Mehedi Hasan, Ishita Ray, Anusua Sarkar, Priyanka Chahal, Sudhan Rackimuthu, Mohammad Yasir Essar · 2021 · Tropical Medicine and Health
  70. Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease
    Peng Xu, Ke Yang, Lei Yang, Zhongli Wang, Fang Jin, Yubao Wang, Jing Feng · 2022 · Frontiers in Microbiology
  71. A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis
    Manse Kim, Claire E. Johnson, Alan A. Schmalstig, Ayano Annis, Sarah E. Wessel, Brian Van Horn, Amanda P. Schauer, Agata A. Exner, Jason E. Stout, Richard Hafner et al. · 2022 · Nature Communications
  72. IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold miners
    Leela R. L. Davies, Malisa T. Smith, Deniz Cizmeci, Stephanie Fischinger, Jessica Shih-Lu Lee, Lenette L. Lu, Erik D. Layton, Alison D. Grant, Katherine Fielding, Catherine M. Stein et al. · 2023 · EBioMedicine
  73. Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti- Mycobacterium tuberculosis agents targeting enoyl acyl carrier protein reductase (InhA)
    Rasha Z. Batran, Ahmed Sabt, Jarosław Dziadek, Asmaa F. Kassem · 2024 · RSC Advances
  74. Mycolyltransferase from Mycobacterium tuberculosis in covalent complex with tetrahydrolipstatin provides insights into antigen 85 catalysis
    Christopher M. Goins, Steven Dajnowicz, Micholas Dean Smith, Jerry M. Parks, Donald R. Ronning · 2018 · Journal of Biological Chemistry
  75. 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity
    Fernanda Souza Macchi, Kenia Pissinate, Anne Drumond Villela, Bruno Lopes Abbadi, Valnês S. Rodrigues-Junior, Débora Dreher Nabinger, Stefani Altenhofen, Nathalia Denise de Moura Sperotto, Adílio da Silva Dadda, Fernanda Teixeira Subtil et al. · 2018 · European Journal of Medicinal Chemistry
  76. Role of VapBC12 Toxin-Antitoxin Locus in Cholesterol-Induced Mycobacterial Persistence
    Sakshi Talwar, Manitosh Pandey, Chandresh Sharma, Rintu Kutum, Josephine Lum, Daniel Carbajo, Renu Goel, Michael Poidinger, Debasis Dash, Amit Singhal et al. · 2020 · mSystems
  77. Repositioning of Isatin hybrids as novel anti-tubercular agents overcoming pre-existing antibiotics resistance
    Rakesh Kumar, Priya Takkar · 2021 · Medicinal Chemistry Research
  78. Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines
    Jhiedon L. Florentino, Rosa Mia L. Arao, Anna Marie Celina Garfin, Donna Mae G. Gaviola, Carlos R. Tan, Rajendra Prasad Hubraj Yadav, Tom Hiatt, Fukushi Morishita, Andrew M. Siroka, Takuya Yamanaka et al. · 2022 · PLoS ONE
  79. Defining the role of neutrophils in the lung during infection: Implications for tuberculosis disease
    E. F. Gaffney, Dearbhla M Murphy, A. Walsh, Sarah A. Connolly, Sharee A. Basdeo, Joseph Keane, James Joseph Phelan · 2022 · Frontiers in Immunology
  80. Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli
    Monica Dallmann-Sauer, Vinicius M. Fava, Stephanus Theron Malherbe, Candice E. MacDonald, Marianna Orlova, Elouise E. Kroon, Aurélie Cobat, Stéphanie Boisson‐Dupuis, Eileen Garner Hoal, Laurent Abel et al. · 2025 · Journal of Clinical Investigation
  81. Screening and identification of plasma lncRNAs uc.48+ and NR_105053 as potential novel biomarkers for cured pulmonary tuberculosis
    Zhibin Li, Yu‐Shuai Han, Liliang Wei, Liying Shi, Wen‐Jing Yi, Jing Chen, Huai Huang, Tingting Jiang, Ji‐Cheng Li · 2020 · International Journal of Infectious Diseases
  82. CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box
    Joel Henrique Ellwanger, Valéria de Lima Kaminski, Andressa Gonçalves Rodrigues, Bruna Kulmann‐Leal, José Artur Bogo Chies · 2020 · International Journal of Immunogenetics
  83. Colorimetric Detection of Mycobacterium tuberculosis ESX-1 Substrate Protein in Clinical Samples Using Au@Pd Nanoparticle-Based Magnetic Enzyme-Linked Immunosorbent Assay
    Sintayehu Kebede Gurmessa, Lemma Teshome Tufa, Jeonghyo Kim, Kang-In Lee, Young-Mi Kim, Van Tan Tran, Huu‐Quang Nguyen, Tae Sun Shim, Jeongkwon Kim, Tae Jung Park et al. · 2020 · ACS Applied Nano Materials
  84. Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis
    Wagdy Mohamed Eldehna, Mahmoud A. El Hassab, Nahla A. Abdelshafi, Fatma Al-Zahraa Sayed, Mohamed Farès, Sara T. Al‐Rashood, Zainab M. Elsayed, Marwa M. Abdel‐Aziz, Eslam B. Elkaeed, Mahmoud Elsabahy et al. · 2021 · International Journal of Pharmaceutics
  85. Prevalence of Diabetes Mellitus in Patients with Tuberculosis: A Prospective Cohort Study
    Panyachot Buasroung, Tananchai Petnak, Prapaipim Liwtanakitpipat, Sasisopin Kiertiburanakul · 2022 · International Journal of Infectious Diseases
  86. A Structural View at Vaccine Development against M. tuberculosis
    Maria Romanò, Flavia Squeglia, Eliza Kramarska, Giovanni Barra, Han‐Gyu Choi, Hwa‐Jung Kim, Alessia Ruggiero, Rita Berisio · 2023 · Cells
  87. Alginate Nanoparticles: A Potential Drug Carrier in Tuberculosis Treatment
    Rakesh P. Patel, Geeta K. Patel, Nikunjana A. Patel, Sudarshan Kumar Singh, Chuda Chittasupho · 2023 · Springer eBooks
  88. Current approaches toward identifying a correlate of immune protection from tuberculosis
    Iman Satti, Helen McShane · 2018 · Expert Review of Vaccines
  89. A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developing Countries
    Ali Khalid, Ruby C.Y. Lin, Jonathan R. Iredell · 2021 · Frontiers in Microbiology
  90. Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infection
    Kamlesh Bhatt, Madhuri Bhagavathula, Sheetal Verma, Graham S. Timmins, Vojo P. Deretic, Jerrold J. Ellner, Padmini Salgame · 2021 · Disease Models & Mechanisms
  91. Stringent Response in Mycobacteria: From Biology to Therapeutic Potential
    Kuldeepkumar Ramnaresh Gupta, Gunjan Arora, Abid R. Mattoo, Andaleeb Sajid · 2021 · Pathogens
  92. Single-cell profiling identifies ACE + granuloma macrophages as a nonpermissive niche for intracellular bacteria during persistent Salmonella infection
    Trung H.M. Pham, Yuan Xue, Susan M. Brewer, Kenneth E. Bernstein, Stephen R. Quake, Denise M. Monack · 2023 · Science Advances
  93. Tobacco smoke exposure recruits inflammatory airspace monocytes that establish permissive lung niches for Mycobacterium tuberculosis
    Björn Corleis, Constantine N. Tzouanas, Marc H. Wadsworth, Josalyn L. Cho, Alice H. Linder, Abigail E. Schiff, Björn Zessin, Fabian Stei, Anca Dorhoi, Amy K. Dickey et al. · 2023 · Science Translational Medicine
  94. PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis
    Flavio De Maio, Basem Battah, Valentina Palmieri, Linda Petrone, Francesco Corrente, Alessandro Salustri, Ivana Palucci, Silvia Bellesi, Massimiliano Papi, Salvatore Rubino et al. · 2018 · Cellular Microbiology
  95. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents
    Charlotte Courtens, Martijn Risseeuw, Guy Caljon, Louis J.R.M. Maes, Anandi Martin, Serge Van Calenbergh · 2019 · Bioorganic & Medicinal Chemistry
  96. All trans retinoic acid as a host-directed immunotherapy for tuberculosis
    Ahmad Z. Bahlool, Conor Grant, Sally‐Ann Cryan, Joseph Keane, Mary P. O’Sullivan · 2022 · Current Research in Immunology
  97. Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile
    Leila Y. Chihab, Rebecca Kuan, Elizabeth Jane Phillips, Simon Alexander Mallal, Virginie Rozot, Mark M. Davis, Thomas J. Scriba, Alessandro Sette, Bjoern Peters, Cecilia S. Lindestam Arlehamn et al. · 2022 · HLA
  98. Electrochemical Biosensors Based on Carbon Nanomaterials for Diagnosis of Human Respiratory Diseases
    Chunmei Li, Bo Che, Linhong Deng · 2022 · Biosensors
  99. Advances in TB testing
    Jayson V. Pagaduan, Ghaith Altawallbeh · 2023 · Advances in clinical chemistry
  100. Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseases
    Annu Devi, Isha Pahuja, Manisha Singh, Akanksha Verma, Debapriya Bhattacharya, Ashima Bhaskar, Ved Prakash Dwivedi, Gobardhan Das · 2023 · Cellular and Molecular Immunology